Venmax Drugs & Pharmaceuticals
add_icon

Venmax Drugs & Pharmaceuticals

24.65
-0.74
(-2.91%)
Market Cap
21.65 Cr
PE Ratio
25.65
Volume
770.00
Day High - Low
27.40 - 22.86
52W High-Low
36.96 - 17.51
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
21.65 Cr
EPS
-0.02
PE Ratio
25.65
PB Ratio
2.20
Book Value
11.53
EBITDA
0.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
-0.24
Debt to Equity
0.11
Forecast For
Actual

Company News

View All News
Caret
neutral
Venmax Drugs & Pharmaceuticals confirms no deviation in use of Rs. 20.05 crores raised through preferential issue for Q3 FY26, with Rs. 3.98 crores utilized till December 31, 2025.
positive
Venmax Drugs and Pharmaceuticals converts warrants worth ₹1.16 crores, allotting 7,75,000 equity shares to three non-promoter investors at ₹20 per share on January 21, 2026.
neutral
Dakshita Jain resigned as Non-Executive Independent Director of Venmax Drugs Pharmaceuticals Limited effective November 24, 2025, citing personal and professional commitments as reasons for her departure. The Board of Directors accepted her resignation during their meeting, with Jain confirming no material reasons exist beyond those stated in her resignation letter.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,752.50
#1 4,20,483.45
38.07
#1 54,729.00
9.71
#1 10,980
16.07
58.54
6,403.50
1,69,992.81
68.67
9,712.00
18.67
2,191
-1.02
57.28
4,369.20
1,47,873.58
64.61
11,539.40
6.99
1,911
26.24
67.10
1,351.60
1,09,178.44
24.01
28,409.50
7.12
5,291
-57.18
48.79
1,294.40
1,08,034.55
19.45
33,741.20
16.73
5,725
-15.28
57.58
2,311.10
1,05,570.77
22.53
22,909.50
13.74
3,306
#1 37.44
68.04
2,245.50
92,695.38
51.46
12,744.20
#1 20.90
2,007
7.65
63.24
906.90
91,255.36
#1 18.47
23,511.00
18.55
4,615
-0.32
49.86
1,210.40
70,300.23
20.36
32,345.60
9.43
3,484
7.59
56.10
5,566.00
66,549.88
27.83
13,458.30
3.70
2,216
1.90
47.86
Growth Rate
Revenue Growth
850.00 %
Net Income Growth
-100.00 %
Cash Flow Change
-2.29 %
ROE
-97.58 %
ROCE
-97.77 %
EBITDA Margin (Avg.)
-100.78 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
2
2
0
0
0
1
0
2
0
0
2
6
Expenses
3
2
1
0
0
1
1
0
0
0
2
5
EBITDA
-0
-0
-1
-0
-0
-0
-0
2
0
0
0
1
Operating Profit %
-5 %
-7 %
-238 %
0 %
-158 %
-54 %
-198 %
0 %
0 %
0 %
-131 %
-18 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-0
-1
-0
-0
-0
-0
2
0
0
0
1
Tax
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-0
-0
-1
-0
-0
-0
-0
2
0
0
0
1
EPS in ₹
-0.15
-0.26
-2.55
-0.46
-0.45
-0.52
-0.31
3.52
0.43
0.12
-0.02
1.70

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
4
3
0
0
0
1
0
0
0
0
5
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
Current Assets
2
1
0
0
0
0
0
0
0
0
5
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
4
3
0
0
0
0
0
0
0
0
5
Total Equity & Liabilities
4
3
0
0
0
1
0
0
0
0
5
Current Liabilities
2
1
2
2
3
3
3
1
1
1
1
Non Current Liabilities
2
2
0
0
0
0
0
0
0
0
0
Total Equity
0
0
-2
-2
-2
-3
-3
-1
-1
-1
4
Reserve & Surplus
-5
-5
-7
-7
-8
-8
-8
-6
-6
-6
-6
Share Capital
5
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
0
0
0
-0
0
0
3
Investing Activities
0
0
0
0
-0
0
0
0
0
0
0
Operating Activities
-0
-0
-1
-0
-0
-0
0
2
0
0
-2
Financing Activities
0
0
1
0
0
0
-0
-2
0
0
5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
15.14 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.69 %
65.69 %
65.57 %
65.57 %
65.57 %
65.57 %
65.64 %
65.64 %
65.64 %
65.66 %
65.66 %
65.66 %
65.66 %
65.66 %
65.67 %
65.54 %
65.24 %
65.01 %
65.36 %
64.25 %
Others
11.03 %
11.03 %
11.15 %
11.15 %
11.15 %
11.15 %
11.07 %
11.07 %
11.07 %
11.06 %
11.06 %
11.06 %
11.06 %
11.06 %
11.04 %
11.17 %
11.47 %
11.86 %
11.51 %
20.61 %
No of Share Holders
0
6,261
6,261
6,257
6,256
6,255
6,255
6,253
6,251
6,250
6,250
6,252
6,251
6,252
6,291
6,657
6,756
6,729
6,764
6,815

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 4.18 4.18
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 4.18 4.18
06 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Feb 2025 21.71 30.27
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 29.69 29.08
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 May 2025 27.90 28.17
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 24.81 28.04
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 30.30 22.14
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 27.27 28.99
07 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2026 24.56 28.20

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 09, 2026
Statement Of Deviation And Variation For The Quarter Ended December 31 2025.Feb 07, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 07, 2026
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 07, 2026
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.Jan 30, 2026
Conversion Of Share Warrants Into EquityJan 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 12, 2025
Board Meeting Outcome for Outcome Of The Board MeetingNov 12, 2025
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30 2025.Nov 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2025
Closure of Trading WindowSep 26, 2025
Board Meeting Outcome for Revised Outcome Of Board MeetingSep 03, 2025
Reg. 34 (1) Annual Report.Sep 02, 2025
Board Meeting Outcome for Outcome Of The Board MeetingSep 02, 2025
Closure of Trading WindowAug 25, 2025
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 25, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity SharesAug 16, 2025
Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.Aug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Financial Results For The Quarter Ended June 30 2025.Jul 23, 2025
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2025.Jul 23, 2025
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 10, 2025
Integrated Filing (Financial)May 09, 2025
Audited Financial Results March 31St 2025.May 09, 2025
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31St 2025.May 09, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AMay 05, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 05, 2025
Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Year And Quarter Ended 31St March 2025.May 01, 2025
Change In Key ManagementApr 26, 2025
Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance OfficerApr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Closure of Trading WindowMar 28, 2025
Board Meeting Outcome for Allotment Of Equity Share Warrants.Mar 21, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Board Meeting Outcome for Financial Results For The Quarter And Nine Months Ended 31.12.2024.Feb 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 06, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024.Feb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025

Technical Indicators

RSI(14)
Neutral
38.74
ATR(14)
Volatile
3.62
STOCH(9,6)
Neutral
37.94
STOCH RSI(14)
Oversold
18.70
MACD(12,26)
Bearish
-0.24
ADX(14)
Weak Trend
20.57
UO(9)
Bearish
56.98
ROC(12)
Downtrend And Accelerating
-13.39
WillR(14)
Oversold
-80.22